INTERACTIONS OF C-REACTIVE PROTEIN WITH THE COMPLEMENT SYSTEM : I. PROTAMINE-INDUCED CONSUMPTION OF COMPLEMENT IN ACUTE PHASE SERA by Siegel, Joan et al.
INTERACTIONS  OF  C-REACTIVE  PROTEIN  WITH  THE 
COMPLEMENT  SYSTEM 
I.  PROTAMINE-INDuCED  CONSUMPTION O]~  COMPLEMENT IN  ACUTE 
PHASE  SERA*' $ 
BY JOAN SIEGEL, ROSEMARIE RENT, ~D  HENRY GEWURZ§ 
(From the Department of Immunology,  Rush Medical College, Chicago,  Illinois  60612) 
(Received for publication 8 April 1974) 
Recent discoveries have reinforced the concept of the essential role of complement 
(C) 1 in host defense and inflammation. These include elucidation of the chemistry of 
the C system and the multiple biologic functions which it mediates, including noncyto- 
toxic release of histamine, chemotactic attraction of neutrophils and other leukocytes, 
immune adherence and binding to B lymphocytes, promotion of phagocytosis, and re- 
actions of membrane damage (3-5). Although it previously had been thought that only 
immune complexes could activate the C system, in recent years numerous additional 
ways of activating single  or groups of components have been defined.  These include 
direct or indirect activation of Cls, C3, and C5 by bacterial or mammalian enzymes 
(6-10), and activation of C3-9 via the alternate or properdin pathway perhaps even 
independent of antibody (3-5, 11, 12). The primary C pathway also can be activated 
nonenzymatically by materials  other  than  antigen-antibody  complexes:  among the 
active substances are IgG aggregated by heat,  carbowax, staphylococcal protein A, 
or reduced insulin  (13-17);  certain polyanions such as polyinosinic acid  (18),  DNA 
(19), and dextran sulfate  (19)  as well as complexes of DNA and lysozyme (20,  21), 
and C-reactive protein  (CRP)  and C-polysaccharide (22).  The ubiquitous nature of 
these nonimmune activating agents suggests that "nonspecific" modes of C activation 
have real biologic importance. 
We recently have been investigating interactions between certain polycations (e.g., 
protamine)  and  polyanions  (e.g.,  heparin)  which  in  normal  human  serum  lead  to 
dramatic activation of the early-acting components of the C system (23, 24). In the 
course of these experiments we observed that protamine sulfate,  even in the absence 
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of heparin, was a  potent activator of C  in the sera of certain patients in the acute 
phase of  inflammation. The studies presented  herein  initially were  directed to  de- 
fining the basis of this protamine-induced consumption of C in acute phase serum. 
It is well known  that characteristic changes occur in the blood during acute in- 
flammation. These include an increased erythrocyte sedimentation rate  (ESR);  the 
appearance or elevation of serum concentrations of CRP, orosomucoid, haptoglobin, 
alpha-1 antitrypsin, antichymotrypsin, ceruloplasmin, certain C and clotting compo- 
nents,  hexosamines, and mucopolysaccharides such  as chondroitin~sulfate; and  de- 
pressed levels of certain other serum proteins including transferrin, alpha-1 and beta 
lipoproteins, albumin, and prealbumin (25-27). The ability of protamine to induce C 
consumption selectively in acute phase sera suggested that one or more of these "acute 
phase reactants" could serve as an activator of the C system. 
In  this  study  we  have  identified the  protamine-reactive  factor  as  a  non- 
dialyzable, heat-stable serum  fraction  which  partitions  with  CRP  during  its 
separation  and  purification,  and  have  reproduced  the  protamine-induced ac- 
tivation of C in normal serum by addition of purified CRP. This CRP-protamine 
interaction results in dramatic consumption  of C1,  C4,  and  C2. Thus,  CRP, 
when reacting with certain polycations such as protamine sulfate, is  a  potent 
activator of the primary C  pathway.  Interactions between  CRP  and its sub- 
strates, via an effect on the C system, may well have an important role in reac- 
tions of host defense, inflammation, and repair. 
Materials and Methods 
Protamine Sulfate.--Protamine sulfate was purchased from Calbiochem, Los Angeles, Calif. 
Barium Sulfate (BaSO4).--BaS04  was purchased from  Fisher Scientific Co., Fair Lawn, 
N.J. 
Phosphoryl choline.--Phosphoryl choline  was  purchased from  Sigma  Chemical  Co.,  St. 
Louis, Mo. 
Sephadex G-g00.--Sephadex G-200 was purchased from Pharmacia Fine Chemicals, Inc., 
Piscataway, N. J. 
Agarose.--Seakem agarose was purchased from  Bio-Medical  Systems,  Rockland, Maine. 
Ethylene Glycd BisO3-AminoethylEther) (EGTA  ).--EGTA  was  obtained  from  Sigma 
Chemical Co. 
Ethylenediaminetetraacaic acid (EDTA).--EDTA was purchased from Fisher Scientific Co. 
Buffers.--Gelatin-veronal-buffered saline with optimum (0.15 mM) calcium chloride and 
(1.0 mM) magnesium  chloride  (GVB  ++) was prepared according  to Mayer (28);  GGVB ++ 
was prepared by mixing equal amounts of GVB  ++ and 5% glucose containing optimum cal- 
cium chloride  and magnesium  chloride  (29);  EDTA and EGTA were  made to 0.01 M  in 
gelatin veronal-buffered  saline at a final pH of 7.4 (EDTA-GVB  and EGTA-GVB,  respec- 
tively). 
Antisera.--Rabbit  antisera against  sheep  erythrocytes and  human  CRP,  respectively, 
were purchased from Hyland Div., Travenol Laboratories, Inc., Costa Mesa, Calif. 
C Components.--Fresh frozen guinea pig serum was obtained from Texas Biological Labora- 
tories, Inc., Fort Worth, Texas.  C1  (29), C2 (29), and  C-EDTA  (28) were  prepared from 
guinea pig serum. 
Cellular Int~mediales.--Sheep erythrocytes (E),  antibody sensitized  erythrocytes (EA), 
EAC1, EAC14, and EAC4 were prepared according  to established methods (28-30) as pre- 
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Human Sera.--Serum samples were prepared from individuals with elevated levels of C RP 
and/or  elevated erythrocyte sedimentation rates,  as well as from both healthy laboratory 
personnd and patients without detectable acute phase alterations, by allowing blood samples 
to stand at room temperature for up to 1 h  and at 4°C for up to 3 h  before centrifugation; 
serum samples were kept at  -70°C before assay.  For certain preparations  of  CRP, serum 
samples from several individuals with elevated CRP levels were pooled. 
Human Ascites Fluid.--Ascites  fluids rich in CRP, made to 0.001  M  with sodium azide, 
were maintained at  --20°C until time of purification. 
Assay  for Hemolytic C and C Component Activities.--The  effect of protamine  on serum 
hemolytic C activities was tested by incubation of 0.2  ml of serum, 0.7 ml GVB  ++, and 0.1 
ml protamine (usually 25/zg) at 30°C for 60 rain.  Titrations of residual total hemolytic C ac- 
tivity and  classical hemolytic C  component activities were performed,  and  the percent C 
consumption determined in the usual way (28, 29, 31).  In certain experiments, heated acute 
phase serum, purified CRP,  test serum fractions or phosphoryl choline were added  to  the 
preincubation mixtures as indicated in the text; the total vol was usually 1.0 ml, and protamine 
always was added last. 
Variations of Ionic Strength and pH.--Ionic strength was  varied by  mixing appropriate 
amounts  of GVB  ++ and  5% glucose with optimum  divalent  cations  to make solutions  of 
0.05, 0.075, 0.10, 0.125, and 0.15 M relative salt concentration (RSC). The pH was varied by 
adding appropriate amounts of NaOH or HC1 (0.1 M) to the serum-buffer mixture immedi- 
ately before assay;  the pH was redetermined immediately at the end of the preincubation 
period. The pH of acute phase sera, in contrast to that of normal sera, always returned  to 
levels of pH 6.5  or higher during  the preineubation intervals.  Experimental results are ex- 
pressed in terms of the initial pH. 
Measurement of CRP.--CRP was  measured  by  the  radial  immunodiffusion  method  of 
Mancini et al.  (32).  An optimum dilution of rabbit-anti-CRP  (0.15 ml antiserum in a  final 
voI of 3.5  ml)  was  incorporated into  the  Seakem agarose  mixture prepared  in phosphate- 
buffered saline, pH 7.6,  containing 0.01  M  EDTA and 0.001  M  NaN3. Test samples were 
reacted to endpoint by overnight diffusion at 26°C, and recorded in the usual way. 
Preparation of CRP.--Purified  CRP was prepared  from pools of human  sera  and  from 
individual aseites fluids both by the method of Osmand  (33), involving chromatography on 
DEAE-cellulose and BioGel A, and by a modification of the method of Ganrot and Kindmark 
(34), involving precipitation with barium sulfate. 
Fractionation of Acute Phase Sera.--To  define  the  protamine-reactive factor(s)  in  acute 
phase  sera, serum pools containing  high  levels of  CRP  were  precipitated with  anhydrous 
Na2SO4 (20% wt/vol), pH 6.0.  The mixture was incubated for 3 h  at 27°C.  The supernate, 
which  contained the protamine-reactive material, was  dialyzed  against  0.1  M  tris,  0.5  M 
NaC1,  0.01  M  EDTA, and 0.01 M  NAN3, pH 7.2, and applied to a  Sephadex G-200  column 
(120 x 5 era) equilibrated in the same buffer. The column was run at 30 ml/h by reverse flow. 
RESULTS 
Effect of Protamine on Hemolytic C and C Component Activities in Acute Phase 
Sera.--We earlier had  observed that  small  amounts  of protamine  sulfate  con- 
sumed  C  when  preincubated  with  the  sera  of  certain  individuals  with  acute 
inflammatory  diseases.  We  determined  the  effect of protamine  (100  ~g/ml  in 
these preliminary experiments)  on total hemolytic C  activity during incubation 
with sera of 40 normal individuals and 58 patients  who were in the acute phase 
of inflammation  as indicated  by  erythrocyte  sedimentation  rates  greater  than 
35 mm/h  and CRP  levels greater than 50 #g/ml. The results are shown in Fig. 
1.49 of the 58 acute phase sera showed C  depletion of at least 50%; the group 634  C-REACTIVE  PROTEIN  AND  THE  COMPLEMENT  SYSTEM 
IO0-  ~ 
90- 
80- 
70- 
Z 
o60- 
0 
~ 40- 
30- 
20- 
I0- 
I 
I 
~L75  --. 19  '÷ 
I 
Iqll, 
__LIP 
¢ 
•  $ 
TI~  I1+10 
o  J~---- 
ACUTE PHASE  NORMAL 
FIG. 1. The effect of protamine on C activity (CHz0) in normal and acute phase sera. Sera 
were designated "normal" on the basis of clinical history, undetectable CRP (< 3 #g/ml), and 
an erythrocyte sedimentation rate (ESR) of <20 mm/h; "acute phase" sera each had CRP 
levels greater than 50 #g/ml and an ESR greater than 35 mm/h. The percent CHs0 consumed 
was determined after preincubafion  of 0.2-ml serum with 100 #g protamine in a final vol of 1.0- 
ml buffered saline (GVB  ++) at 37°C for 60 min. Protamine induced substantial consumption  of 
C selectively in the acute phase sera. 
mean value was 75  -4-  19 %  C consumed. By contrast, none of the normal in- 
dividuals displayed as much as 50 % depletion of C, with a group mean value of 
only  11  +  10%  C  consumed.  Hence,  protamine-induced  consumption of  C 
regularly could be demonstrated in individuals in the acute phase. 
We next determined  the classical  hemolytic C  component depletion profile 
(Fig.  2).  The predominant component depleted  was C1,  levels of which  were 
consistently reduced by at least 90%; large amounts of C4 and C2  also were 
consumed. Only minimal depletion of C3-9 was observed, reflecting markedly 
inefficient fluid  phase  formation of the  C3  convertase.  Thus,  protamine  ap- 
parently induced activation of the classical  primary pathway at the level of C1 
during incubation in  acute phase  sera. 
Conditions Optimal  for Protamine-Induced Consumption of C.--Varying doses 
of protamine sulfate  (5-1,000 #g/ml)  were compared for their  ability to con- 
sume C  in acute phase and normal sera,  respectively (Fig. 3).  Substantial  C 
consumption was seen  even when preincubations were performed with  10 #g 
protamine/ml, and 25-100 #g protamine/ml induced maximum depletion of C. lOAN  SIEGEL  ROSEMARIE  RENT,  AND  HENRY  GEWURZ  635 
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FIG. 2.  The effect of preincubation with protamine on classical C component activities in 
acute phase and normal sera preincubated as in Fig. 1. Acute phase sera, selected from patients 
who showed total CHs0 consumption of 70% or greater, were used for this and subsequent 
experiments unless otherwise noted.  Dramatic consumption of C1, C4, and C2 was seen in 
the acute phase sera. 
These amounts of protamine had no effect upon hemolytic C activity in normal 
sera. Somewhat larger amounts of protamine (250 ~g/ml) resulted in reduced 
amounts of C consumption in acute phase sera and were slightly "anticomple- 
mentary" in normal sera, while still larger amounts of protamine (500-1,000 
#g/ml) were C consuming both in acute phase and normal sera. A concentra- 
tion of 25 #g/ml protamine, 10 times lower than the 250 #g/ml dose which was 
C consuming in normal sera, therefore was used in all subsequent experiments 
unless otherwise noted. 
Protamine-induced consumption of C  was markedly dependent upon  time 
and temperature  (Fig. 4). When protamine was preincubated in acute phase 
serum  at 37°C,  22°C,  14°C,  and 0°C,  for varying intervals up  to  180  rain, 
hemolytic C activity was most rapidly depleted at 37°C; 80% C consumption 
was seen within 15 min and there was no observable residual hemolytic activity 
after 60 rain. C was consumed more slowly (55 % at 15 min) at room tempera- 
ture (22°C) but also was completely depleted after 60 min of preincubation; the 
reaction proceeded less efficiently, though distinctly, when preincubations were 636  C-REACTIVE  PROTEIN  AND  THE  COMPLEMENT  SYSTEM 
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Fie. 3.  The effect of preincubation with varying concentrations of protamine on C activity 
in acute phase and normal sera. The percent CHs0 consumed was determined after 60 rain 
preincubation at 30°C in mixtures containing 0.2-ml serum in a final vol of 1.0 ml; the reac- 
tion was performed at pH 7.5 and 0.10 M RSC. Low dosages of protamine (10-100 #g) induced 
significant C  consumption preferentially in the acute phase sera.  Dosages greater than 250 
#g protamine were C consuming in both normal and acute phase sera. 
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#g protamine in acute phase serum. Depletion of C, observed at all temperatures, was most 
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carried out at 14°C and 0°C, respectively. No consumption of C was  observed 
in the normal control sera under these preincubation conditions. Further  ex- 
perimentation indicated  that  a  60 min preincubation period at 30°C  offered 
the preferable reaction system, since maximum total hemolytic C activity was 
consumed with minimal "spontaneous" depletion of C activity in sera incubated 
in  the  absence of protamine.  This  condition was  used  in  all  subsequent  ex- 
periments. 
Protamine-induced consumption  of C  was  maximal  between  0.05-0.10  M 
relative salt concentration (RSC). Reduced C consumption was seen during pre- 
incubations  at  higher  ionic  strengths,  while  preincubation  at  lower  ionic 
strengths (including those at 0.05 M  RSC) resulted in spontaneous depression 
of hemolytic C activity. An RSC of 0.10 M proved to be optimal for the preincu- 
bation time and temperature selected. The reaction was favored at neutral pH 
levels with optimum consumption seen between pH 7.5  and 8.0;  marked re- 
duction of protamine-induced C consumption was observed at pH 9.5. Prota- 
mine did not induce consumption of C  in acute phase sera in the presence of 
either 0.01  M  EDTA or 0.01  M  EGTA, indicating a  requirement for calcium 
ions. The reaction was not affected by the presence of 0.1% gelatin in the buffer 
system. The optimal preincubation conditions, adopted for all subsequent ex- 
periments, consisted of a final serum concentration of 20 % in veronal-buffered 
NaCl-glucose  (RSC  0.10  M;  pH  7.5) with  gelatin  and  divalent  cations  as 
described (28); all preincubations were carried out for 60 min at 30°C. 
Isolation  of the  Factor  in  Acute  Phase  Serum  Responsible for  Protamine- 
Induced C Consumption.--The protamine-reactive substance(s)  in acute phase 
sera was found to be heat stable and nondialyzable. Small amounts of acute 
phase serum (e.g., 25 #1), heated to 56°C for 30 min and dialyzed for 2 h against 
multiple changes of buffer in the cold, when added to  100 #1 normal control 
serum  resulted in maximal  consumption of C  upon  preincubation with  pro- 
tamine; heated,  dialyzed normal  serum,  even in  much higher  amounts,  had 
no such effect. 
To begin separation of the active substance(s),  a  pool of acute phase sera 
was precipitated by adjusting the pH to 6.0 with  1 N  HCI and adding 20% 
Na2SO4 ; substantial  protamine-reactive material was recovered in the super- 
natant fraction, while none was observed in the redissolved precipitate. All  of 
the recoverable CRP was in the supernatant fraction. The active supemate was 
applied to a Sephadex G-200 column; the elution profile (Fig. 5) shows that the 
peak protamine-reactive material eluted between the IgG and albumin markers, 
along with  the elution peak of CRP, and corresponded well with the known 
CRP mol wt of approximately 120,000-140,000 daltons (33, 35). Our attention 
therefore was directed to the possible identity of the protamine-reactive factor 
with  CRP.  Further  purifications  were  performed  according  to  previously 
established procedures for isolation of CRP (see below). 
Association  of the Acute  Phase Reactivity  with CRP,--The  level of CRP  in 
over 90 sera taken from both normal individuals and patients in the acute phase ODzao 
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protamine-reactive material  eluted with  the peak  of CRP  between  the IgG and  albumin 
markers. 
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was compared with the percent C consumed when these sera were preincubated 
with protamine  (Fig.  6).  A  significant correlation was observed between the 
level of CRP and the percent of protamine-induced C consumption. An analysis 
of this association by the arc sine transformation showed a correlation coefficient 
of 0.78. No serum with less than 50 #g/ml CRP showed as much as 40% C con- 
sumption when preincubated with protamine, while all sera with greater than 
200 #g/ml CRP exhibited C consumption of at least this degree. 
The participation of CRP in protamine-induced consumption of C in acute 
phase sera was substantiated in yet another way. Phosphoryl choline is known 
to be a  major substrate for CRP,  and is known to inhibit its reactions with 
C-polysaccharide as well as with certain other choline-containing compounds 
with which CRP can interact (36). We tested the ability of small amounts of 
this  substance  to inhibit  the  protamine-induced  C  consumption  during  pre- JOAN  SIEGEL,  ROSEMARIE RENT,  AND HENRY  GEWURZ  639 
I00- 
90- 
80- 
70- 
z 
-°60- 
~  40- 
20" 
I0- 
O- 
0 o 
OO0  •  OOQ  •  • 
QO  ~  •  •  • 
O  O  •  • 
•  O, OO 
O  o 
I  • 
•  O  °  • 
I- 
•  II~e e 
o 
00  • 
i  u  i  i 
,oo  2Go  3Go  460 
C-REACTIVE  PROTEIN  -  ~g/ml 
Fro. 6.  Correlation of serum CRP levels with protamine-induced consumption of C. The 
column at the left, denoted by the asterisk, represents normal laboratory personnel; all other 
points represent randomly selected hospitalized patients. The arc sine transformation gives a 
correlation coefficient of 0.78. 
incubation in acute phase sera  (Fig. 7).  Substantial inhibition was seen with 
amounts of phosphoryl choline as low as 5 #g/ml; 1-200  ~g/ml of phosphoryl 
choline had no inhibitory effect either upon hemolytic C  activity, or C  con- 
sumption by aggregated human gamma globulin (AHGG) or zymosan, in these 
normal or acute phase sera. Therefore, it appeared most likely that protamine 
was reacting with CRP  to produce the observed consumption of C in acute 
phase serum. 
Addition  of Purified  CRP to Normal Sera.--The  effects of adding purified 
preparations of serum or ascites fluid CRP to normal sera was investigated. 
The supernate of CRP-rieh serum precipitated in NasSO,  (20%  wt/vol, pH 
6.0)  was adsorbed to BaSO4  (34)  and resolubilized; it contained all the anti- 
genitally identifiable CRP  and  was free of other  serum  proteins  and  acute 
phase reactants as indicated by immunoelectrophoresis and polyacrylamide gel 
electrophoresis.  Ascites  CRP  was  purified  by  chromatography  on  DEAE- 
cellulose  and BioGel A  (33). These CRP preparations, when added to normal 
human serum, were found to induce substantial consumption of C when pre- 
incubated with small amounts of protamine (Fig. 8). 100 #g of CRP under these 
conditions induced  consumption of  approximately 50%  of  the  available  C, 
whereas 500 #g of CRP led to a C consumption of 80-90 %. This degree of C 
consumption  was  remarkably  similar  to  that  produced by heat-inactivated 640  C-REACTIVE  PROTEIN  AND  THE  COMPLEMENT  SYSTEM 
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Fro.  7.  Effect  of  phosphoryl  choline  on  protamine-induced  consumption  of  C  in  acute 
phase serum. Small amounts of phosphoryl choline (10 #g/ml) completely inhibited protamine- 
induced consumption of C in acute phase serum, while even much larger amounts (up to 200 
#g/ml) had no effect upon C consumption induced by either AHGG or zymosan. 
acute phase serum with comparable amounts of CRP, and also was equivalent 
to the average reactivity of the patient groups at corresponding levels of CRP 
(Fig. 8). 
The classical C component depletion profile was determined when protamine 
was  preincubated  with these  normal serum-CRP  mixtures  (Fig.  9).  Marked 
protamine-induced  consumption  of C1,  C4,  and  C2  was observed  in reaction 
mixtures containing either serum or ascites  CRP; the CRP preparations them- 
selves showed minimal  but distinct  C4-  and  C2-consuming  activities,  respec- 
tively. Only minimal,  if any,  consumption  of C3-9 could be observed.  Hence, 
the  C  component  depletion  profile induced  by protamine  in normal  sera  to 
which CRP was added was similar to that seen  when the parent  acute  phase 
sera were preincubated with protamine. We therefore conclude that protamine 
induces  consumption  of  C  in  acute  phase  serum  by  interaction  with  CRP, 
and further,  that  this  interaction  involves activation of the primary  C path- 
way at the level of C1. 
DISCUSSION 
We had previously  observed  that  interactions  between certain  polyanions 
and polycations,  like interactions  between antigen  and antibody,  can result in JOAN  SIEGEL,  ROSEMARIE  RENT,  AND  HENRY  GEWURZ  641 
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FIo. 8.  Effect of protamine  on C consumption in normal serum to which heat-inactivated 
acute phase serum or purified CRP was added. In both instances C consumption in propor- 
tion  to the amount of CRP added was observed. A quantitatively similar relationship  was 
seen between C consumption  and  CRP concentration  when the patients  in the population 
study cited in Fig. 6 were grouped according to CRP level. 
consumption  of large  amounts  of  C  when  they occur  in  fresh  normal  serum 
(23, 24). In the course of these studies we had noted that whereas small amounts 
of protamine  had  no  effect upon  C  activity  during  preincubations  in  normal 
serum,  the addition  of protamine  to sera from individuals  with  acute inflam- 
matory  diseases  frequently  resulted  in  consumption  of  large  amounts  of  C. 
Since it  is well known  that  numerous  highly charged substances  are  found in 
the  blood  stream  during  the  "acute  phase",  including  mucopolysaccharides 
such as chondroitin sulfate,  and perhaps even heparin  (25),  we thought it not 
unlikely that one of these materials could be reacting with protamine to initiate 
the consumption of C which we had observed.  Indeed,  it seemed  possible  that 
one or more of the acute phase reactants  could in  this  way serve as  an  entry 
point to the potential  for inflammation and repair which resides  in the  C  sys- 
tem. We therefore initiated  these studies to determine the underlying basis for 
protamine-induced consumption of C  in acute phase sera. 
We found, to our surprise, that the predominant acute phase reactant capable 
of reacting with this polycation to result in consumption of C  was CRP.  CRP 
was present  in all  sera in which protamine-induced  consumption of C  was ob- 642  C-REACTIVE  PROTEIN  AND  THE  COMPLEMENT  SYSTEM 
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FIG.  9.  Effect of protamine on consumption of classical C  components in normal serum 
to which purified serum or ascites CRP was added.  Substantial consumption  (>90%)  of C1, 
C4,  and C2 was observed in the presence of CRP (200/xg/ml). 
served, and the degree of C consumption correlated remarkably well (p =  0.78) 
with the amount of CRP which was present. When acute phase sera were par- 
titioned,  the  protamine-reactive material  was  found only in  fractions which 
contained CRP. Addition of highly purified CRP prepared either from serum 
or ascites fluid rendered normal serum capable of displaying C depletion upon 
preincubation with protamine, and to a degree which correlated well with the 
degree  of  C  consumption  observed  in  acute  phase  sera  containing  similar 
amounts of CRP. Finally, phosphoryl choline, a known suhstrate of CRP (36), 
could inhibit protamine-induced consumption of C in acute phase sera as  well 
as in normal sera to which CRP had been added, while it had no effect upon 
consumption of C by other agents such as AHGG or zymosan. We  concluded 
that the C consumption observed indeed was mediated by CRP. 
This reaction appeared to involve an activation of the primary C  pathway. 
Marked consumption of C components C1, C4, and C2, with minimal, if any, 
consumption of C3-9 was observed both in acute phase sera and in normal sera 
to which  CRP  had been added.  The reaction was markedly dependent upon 
time, temperature, and calcium ions, and was inhibited when large amounts of 
protamine were added. The ionic strength optimum for maximal C consumption JOAN SIEGEL, ROSEMARIE RENT, AND HENRY GEWURZ  643 
(0.10 M RSC) is optimum for activation of C1, while the optimal pH was 7.5- 
8.0. Very small amounts of protamine, as little as 5 #g/ml, sufficed to activate 
the primary C pathway via CRP. Thus, CRP, like IgG and IgM, can react with 
certain extrinsically derived substances to result in activation of the C system, 
and it seems not unlikely that this is one of the major functions of CRP (22). 
Kaplan and Volanakis had reported that choline phosphatides (e.g.,  lecithin 
and sphingomyelin) and C-polysaccharide reacted with CRP to result in con- 
sumption of C (22). We were surprised to find that protamine and certain (but 
not all) other polycations including polymers of poly-L-lysine and lysine-rich and 
arginine-rich histones also could initiate C consumption via CRP.  * The major 
substrates of CRP are considered to be phosphoryl choline, phosphate esters, 
and related compounds; substances rich in  these groups,  such as C-polysac- 
charide, lecithin, and membrane-derived choline-containing compounds, have 
been observed to be strongly reactive with CRP  (36, 37).  Zymosan (38)  and 
certain sulphated polysaccharides including agar (34), and heparin and dextran 
sulfate under conditions of low ionic strength (37), also have been reported to be 
reactive with CRP. It appears that polycations represent an additional group of 
substrates reactive with CRP. Perhaps CRP can react with other polycationic 
materials such as various leukocyte-derived cationic proteins in the fluid phase, 
or with cationic substrates exposed on or attached to cell surfaces under given 
conditions, to result in activation and/or attachment of the C components and 
initiation or extension of the inflammatory process. 
Therefore,  CRP  can  be  considered  among  the  agents  which  can  lead  to 
"nonimmune" activation of the first component of C. Nonimmune activation 
of C1 has been known to occur in at least three distinct ways. Firstly, gamma 
globulins aggregated or coprecipitated by heating or  chemical  coupling  (13, 
14),  carbowax  (15),  staphylococcal protein A  (16),  or  insulin  (17)  can  ac- 
tivate C1  independently of an antigen-antibody interaction, presumably via 
an interaction between gamma globulin and Clq. A second way involves direct 
interaction with Clq, and has been seen with agents such as polyinosinic acid 
(18),  and polyanions such  as DNA  (19)  and dextran sulfate  (19).  Thirdly, 
plasmin, trypsin, and lysosomal enzymes (6) have been found to activate C1 di- 
rectly at the level of Cls.  It has not yet been established by which of these 
routes polyanion-polycation complexes such as DNA and lysozyme (20, 21) or 
heparin  and  protamine  (23,  24)  activate  C1;  since  certain  polyanions  can 
activate  Clq  directly,  it  seems  likely that  aggregates  involving  these  sub- 
stances can do so  at  least  as  well.  We would speculate that the  CRP-prot- 
amine  (polycation)  interaction also  activates  C  at  the  level of Clq.  What- 
ever the underlying mechanism, CRP serves as a route of access to C1 which is 
selectively available during acute inflammation. Thus, CRP seems to provide to 
2 Siegel, J., A. P. Osmand, and H. Gewurz. Interactions of C-reactive protein with the 
complement system. II. CRP-mediated consumption of complement by poly-L-lysine  poly- 
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its substrates nonimmune entry into the primary C pathway analogous to that 
which the early-acting factor(s) in the properdin system seem to provide to the 
alternate C pathway for certain of the substances with which it interacts (11). 
The biologic significance of this avenue of C1 activation remains to be defined. 
Most but not all of the known biologic  effects of C  are mediated via the 
biologically  potent  C3-9  components  (3-5);  however,  the  protamine-CRP 
interaction resulted in minimal, if any, depletion of C3-9.  It is not yet clear 
whether polycations simply cannot support  the development of the  C3  con- 
vertase, or whether larger or membrane-associated polycationic materials are 
necessary to display this effect. The CRP-mediated activation of C does involve 
substantial consumption of C1,  C4, and C2. Perhaps utilization of these com- 
ponents in itself reflects an important event in inflammation, defense or repair, 
such  as release  of  a  kinin-like  peptide  (39),  deposition  of  early-acting  C 
components in  preparation  for  immune  adherence  (40),  immunoconglutina- 
tion  (41),  viral  neutralization  (42),  binding  of  B  lymphocytes (43,  44),  or 
other  functions not yet appreciated.  In  any case,  since  CRP,  like immuno- 
globulins, can activate the C system, these studies serve to extend the analogies 
between CRP and antibody which already include  similarity of  amino  acid 
composition (33)  and  ability  to  induce  reactions  of  precipitation  (45),  ag- 
glutination (46),  opsonization (47),  mitogenesis  (48),  and capsular  swelling 
(49). Whether CRP shares with antibody other of its biologic functions, such as 
the ability to bind to B cells, platelets, and rheumatoid factor, remains to be 
seen. 
A role of CRP as an agent which consumes C raises the possibility that other 
reactants  of  the  acute  phase  may also  have  this  capacity.  The  ubiquitous 
appearance  of  the  "acute  phase  response"  in  vertebrate  and subvertebrate 
species may have an underlying survival advantage in the delivery into the 
circulation of materials  with  a  capacity  to  enhance,  limit,  or  modulate  in- 
flammatory and/or repair reactions via the C system. 
SUMMARY 
Protamine  sulfate was  found  to  consume large  amounts  of  C  selectively 
during preincubation with sera of individuals in the "acute phase". Marked 
depletion of C1,  C4, and C2 with minimal, if any, depletion of C3-9,  was ob- 
served. The consumption was time and temperature dependent, occurring most 
rapidly and extensively at 37°C, 0.10 M relative salt concentration and pH 7.5- 
8.0;  it required calcium ions.  It was mediated by a heat-stable nondialyzable 
factor which separated with C-reactive protein (CRP) during fractionation and 
purification, correlated with serum CRP levels, and, like other known reactivi- 
ties of CRP, was inhibited by phosphoryl choline. Preparations of CRP purified 
either from serum or ascites resulted in consumption of large amounts of C1, C4, 
and C2 when preincubated with normal serum and protamine. We conclude that 
CRP is a potent activator of the C system at the level of C1, and that polycat- JOAN SIEGF.,L~ ROSEMARIE RENT~ AND HENRY GEWURZ  645 
ions such as protamine sulfate are substrates of CRP which can bring about this 
activation. It seems not unlikely that one role of CRP in health  and disease 
involves its ability to interact with the  C  system. 
The authors gratefully acknowledge the thoughtful assistance and technical expertise of 
John White, Kathy Petras, and Carolyn Fortman. 
Note Added in Proofi--Studies  by Kaplan and Volanakis concerning  their discovery 
and elucidation  of the interaction between CRP, C-polysaccharide and the C system 
have recently been published 1974. J. Immunol.  112:2135 and 118:9. 
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